IRCT20190911044744N1招募中3 期
Comparison of the effect of silymarin and placebo on serum liver enzyme level in patients with trauma in the Intensive Care Unit in Rajaei hospital
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 no limit（—）
- 性别
- All
入选标准
- •People aged 16 or over
- •Not taking a known hepatotoxic drug
- •Not taking oral silymarin during the past day
- •No confirmed history of allergic reactions following oral administration of silymarin
- •Alanine aminotransferase (ALT) levels more than 2-fold above normal (> 70 IU / L) up to 4-fold above normal Or aspartate aminotransferase (AST) levels more than 2-fold above normal (> 70 IU / L) up to 4-fold above normal
- •Not taking concomitant antioxidants or compounds such as vitamin A, C, E and N-acetyl cysteine
- •Oral tolerance to medications
排除标准
- •Pregnancy or lactation
- •History of advanced liver disease
研究者
相似试验
尚未招募
3 期
Effects of topical gel Silymarin versus placebo as an adjuvant therapy on pain management in patients with painful diabetic neuropathyPainful diabetic neuropathy.Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecifiedE08.40IRCT20120215009014N501Hamedan University of Medical Sciences50
招募中
3 期
Effect of Sylimarin versus placebo on the reduction of liver complication of Teriflunomide in patients with multiple sclerosisMultiple sclerosisIRCT20120215009014N467Hamedan University of Medical Sciences42
已完成
3 期
The effect of silymarin on methadone poisoningIRCT20210216050377N1Shahre-kord University of Medical Sciences64
已完成
2 期
Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to PlaceboDrug-induced Liver InjuryNCT05144217Prof. Dr. Frank Behrens19
尚未招募
4 期
COMPARING EFFECTIVENESS OF CAPSULE SILYMARIN WITH THAT OF SM FIBRO CAPSULE IN THE MANAGEMENT OF ORAL SUBMUCOUS FIBROSISCTRI/2024/01/061326KAKARLA VENKATA SUSMITHA